J Goodwin to Antineoplastic Agents
This is a "connection" page, showing publications J Goodwin has written about Antineoplastic Agents.
Connection Strength
0.423
-
Ninan MJ, Liu Y, Kuo YF, Goodwin JS. Hospitalization for Toxicity in Patients Treated With Rituximab. Am J Clin Oncol. 2017 Apr; 40(2):125-132.
Score: 0.295
-
Reyes-Ortiz CA, Goodwin JS, Zhang DD, Freeman JL. Socioeconomic status and chemotherapy use for melanoma in older people. Can J Aging. 2011 Mar; 30(1):143-53.
Score: 0.048
-
Ding Y, Qiao A, Wang Z, Goodwin JS, Lee ES, Block ML, Allsbrook M, McDonald MP, Fan GH. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci. 2008 Nov 05; 28(45):11622-34.
Score: 0.041
-
Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med. 2003 Jan 21; 138(2):90-7.
Score: 0.028
-
Mahdi N, Faia LJ, Goodwin J, Nussenblatt RB, Sen HN. A case of autoimmune retinopathy associated with thyroid carcinoma. Ocul Immunol Inflamm. 2010 Aug; 18(4):322-3.
Score: 0.012